Asset Details
Do you wish to reserve the book?
Cortisol inhibits cholinergic vasodilatation in the human forearm
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cortisol inhibits cholinergic vasodilatation in the human forearm
Do you wish to request the book?
Cortisol inhibits cholinergic vasodilatation in the human forearm
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cortisol inhibits cholinergic vasodilatation in the human forearm
2000
Overview
Exogenous cortisol raises blood pressure (BP) in humans and there is accumulating evidence of abnormalities of glucocorticoid activity in essential hypertension. In this study we tested the hypothesis that exogenous cortisol attenuates the cholinergic dilator response in the forearm circulation. Fourteen healthy normotensive men were studied. Using bilateral forearm venous plethysmography, we examined forearm blood flow responses to intra-arterial acetylcholine (ACh) and sodium nitroprusside (SNP) pre- and post-
N
G
-monomethyl-
l-arginine (LNMMA) after 2 or 5 days of oral cortisol or placebo in a randomized, double-blind crossover study.
Exogenous cortisol increased supine systolic (
P
< .05) and standing systolic (
P
< .05) BP and produced expected metabolic changes and suppressed serum cortisol concentration (
P
< .001). Baseline forearm blood flow did not differ between placebo and cortisol treatments at 2 or 5 days. Cholinergic vasodilatation was impaired after cortisol administration, reaching statistical significance at 5 days (
P
< .05). Cortisol did not affect responses to SNP.
N
G
-monomethyl-
l-arginine inhibited cholinergic vasodilatation in placebo-treated groups but had no additional effect in the presence of cortisol.
These results support our hypothesis and suggest that the mechanism of impaired cholinergic dilatation in glucocorticoid-treated subjects involves abnormalities of the endothelial nitric oxide system.
Publisher
Elsevier Inc,Oxford University Press,Elsevier Science
